United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

Publisher Name :
Date: 15-Sep-2016
No. of pages: 100
Inquire Before Buying

Notes:

Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)

Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies sales (consumption) of Drugs for Respiratory Syncytial Virus (RSV) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Ablynx

- ADMA Biologics

- Agilvax

- AlphaVax

- AmVac

- Aridis Pharmaceuticals

- Artificial Cell Technologies

- Astellas Pharma

- AstraZeneca

- Bavarian Nordic

- Biota Pharmaceuticals

- Celltrion

- Codagenix

- Crucell

- CureVac

- Emergent

- Roche

- GenVec

- Gilead Sciences

- GlaxoSmithKline

- Humabs BioMed

- Novavax

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Ribavirin

- Bronchodilator

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into

- Infants (Under 6 Month Old)

- Babies & Children

- Adults

United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

Table of Contents
United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021
1 Drugs for Respiratory Syncytial Virus (RSV) Overview
1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)
1.2.1 Ribavirin
1.2.2 Bronchodilator
1.2.3 Type III
1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)
1.3.1 Infants (Under 6 Month Old)
1.3.2 Babies & Children
1.3.3 Adults
1.4 USA Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)
1.4.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
1.4.2 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
1.4.3 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
2 USA Drugs for Respiratory Syncytial Virus (RSV) Competition by Manufacturers
2.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufactures (2015 and 2016)
3 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume and Value) by Type
3.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
3.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
4 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume) by Application
5 USA Drugs for Respiratory Syncytial Virus (RSV) Manufacturers Analysis
5.1 Ablynx
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
5.1.2.1 Ribavirin
5.1.2.2 Bronchodilator
5.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
5.2 ADMA Biologics
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Ribavirin
5.2.2.2 Bronchodilator
5.2.3 Pharmaceuticals Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
5.3 Agilvax
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Agilvax Product Type and Technology
5.3.2.1 Ribavirin
5.3.2.2 Bronchodilator
5.3.3 Agilvax Sales, Revenue, Price of Agilvax (2015 and 2016)
5.4 AlphaVax
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 AstraZeneca Product Type and Technology
5.4.2.1 Ribavirin
5.4.2.2 Bronchodilator
5.4.3 AlphaVax Sales, Revenue, Price of AlphaVax (2015 and 2016)
5.5 AmVac
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 AmVac Product Type and Technology
5.5.2.1 Ribavirin
5.5.2.2 Bronchodilator
5.5.3 AmVac Sales, Revenue, Price of AmVac (2015 and 2016)
5.6 Aridis Pharmaceuticals
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Aridis Pharmaceuticals Product Type and Technology
5.6.2.1 Ribavirin
5.6.2.2 Bronchodilator
5.6.3 Aridis Pharmaceuticals Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
5.7 Artificial Cell Technologies
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Artificial Cell Technologies Product Type and Technology
5.7.2.1 Ribavirin
5.7.2.2 Bronchodilator
5.7.3 Artificial Cell Technologies Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
5.8 Astellas Pharma
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Astellas Pharma Product Type and Technology
5.8.2.1 Ribavirin
5.8.2.2 Bronchodilator
5.8.3 Astellas Pharma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
5.9 AstraZeneca
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 AstraZeneca Product Type and Technology
5.9.2.1 Ribavirin
5.9.2.2 Bronchodilator
5.9.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.10 Bavarian Nordic
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Bavarian Nordic Product Type and Technology
5.10.2.1 Ribavirin
5.10.2.2 Bronchodilator
5.10.3 Bavarian Nordic Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
5.11 Biota Pharmaceuticals
5.12 Celltrion
5.13 Codagenix
5.14 Crucell
5.15 CureVac
5.16 Emergent
5.17 Roche
5.18 GenVec
5.19 Gilead Sciences
5.20 GlaxoSmithKline
5.21 Humabs BioMed
5.22 Novavax
6 Drugs for Respiratory Syncytial Virus (RSV) Technology and Development Trend
6.1 Drugs for Respiratory Syncytial Virus (RSV) Technology Analysis
6.2 Drugs for Respiratory Syncytial Virus (RSV) Technology Development Trend
7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
Figure Ribavirin Picture
Figure Bronchodilator Picture
Table Applications of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application in 2015
Figure Infants (Under 6 Month Old) Examples
Figure Babies & Children Examples
Figure Adults Examples
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Table Ablynx Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
Table ADMA Biologics Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
Table Agilvax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
Table AlphaVax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
Table AmVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table Artificial Cell Technologies Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table AstraZeneca Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Bavarian Nordic Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
Table Biota Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)
Table Celltrion Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)
Table Codagenix Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)
Table Crucell Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)
Table CureVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)
Table Emergent Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)
Table Roche Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)
Table GenVec Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Humabs BioMed Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)
Table Novavax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)
  • Global Bacillus Subtilis Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Mar-2017        Price: US 3480 Onwards        Pages: 117
    Bacillus subtilis, known also as the hay bacillus or grass bacillus, is a Gram-positive, catalase-positive bacterium, found in soil and the gastrointestinal tract of ruminants and humans. A member of the genus Bacillus, B. subtilis is rod-shaped, and can form a tough, protective endospore, allowing it to tolerate extreme environmental conditions. B. subtilis has historically been classified as an obligate aerobe, though evidence exists that it is a facultative aerobe. B. subtilis is considered t......
  • Asia-Pacific Plasminogen Activator Inhibitor Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Plasminogen Activator Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Plasminogen Activator Inhibitor for these regions, from 2012 to 2022 (forecast), including - China - Japan......
  • Asia-Pacific Natriuretic Peptide Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Natriuretic Peptide for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea -......
  • Asia-Pacific Demineralized Bone Matrix Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Demineralized Bone Matrix market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Demineralized Bone Matrix for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Ko......
  • Asia-Pacific Creatine Kinase Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Creatine Kinase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Creatine Kinase for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Cardiac Troponin Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Cardiac Troponin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Cardiac Troponin for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwa......
  • Asia-Pacific Argatroban Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the Asia-Pacific Argatroban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Argatroban for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - I......
  • EMEA (Europe, Middle East and Africa) Herbal Oil Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Herbal Oil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Herbal Oil for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Veterinary Pain Management Drugs Market Report 2017
    Published: 23-Mar-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Veterinary Pain Management Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs